A breakthrough in cancer screening has the potential to revolutionize the way women are checked for womb cancer. Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for checks after experiencing heavy bleeding.
The current approach involves a series of agonizing and often uncomfortable medical tests, including ultrasounds, blood tests, and endoscopies. While these tests can help diagnose the condition, they are not always 100% accurate and can lead to unnecessary anxiety and distress for patients. The AI-powered blood test is designed to provide a more accurate diagnosis in a shorter amount of time.
The NHS AI blood test uses advanced algorithms to analyze a woman's blood samples and identify potential signs of womb cancer. If the results indicate a high risk, further testing may be recommended. This innovative approach has the potential to reduce the number of unnecessary invasive checks, allowing women to get back on their feet sooner. As the technology continues to improve, it could become an important tool in the fight against womb cancer and other gynecological conditions.